Teva Pharmaceutical Fundamental Relationships

TEVA -- Israel Stock  

ILS 5,102  50.00  0.97%

The Drivers Module shows relationships between Teva Pharmaceutical's most relevant fundamental drivers and provides multiple suggestions of what could possibly affect the performance of Teva Pharmaceutical Industries Limited over time as well as its relative position and ranking within its peers. Also please take a look at World Market Map

Teva Pharmaceutical Price to Sales vs. Total Debt Fundamental Analysis

Teva Pharmaceutical Industries Limited is currently regarded number one company in total debt category among related companies. It is rated second in price to sales category among related companies . The ratio of Total Debt to Price to Sales for Teva Pharmaceutical Industries Limited is about  10,478,260,870 
Teva Pharmaceutical Industries Limited is currently regarded number one company in total debt category among related companies. Total debt of Drug Manufacturers - Specialty & Generic industry is at this time estimated at about 32.16 Billion. Teva Pharmaceutical totals roughly 28.92 Billion in total debt claiming about 90% of equities under Drug Manufacturers - Specialty & Generic industry.
Total debt  Revenue  Valuation  Workforce  Capitalization
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principle payments will eventually prevent the firm from borrow excessively.
Teva Pharmaceutical 
Total Debt 
 = 
Bonds 
+  
Notes 
=
28.92B
In most industries, total debt may also include current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meaningful to compare total debt amounts between companies that operate within the same sector.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Teva Pharmaceutical 
P/S 
 = 
MV Per Share 
Revenue Per Share 
=
2.76X
The most important factor to remember is that the price of equity takes a firm's debt into account, whereas the sales does not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.

Teva Pharmaceutical Price to Sales Comparison

Teva Pharmaceutical Fundamental Comparison

Search macroaxis.com